ArticleCellular oncology (Dordrecht, Netherlands)2019

Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.

Florian P Reiter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.